Skip to main content

Advertisement

Log in

Enhanced Platelet Activation in Patients with Atopic Eczema/Dermatitis Syndrome

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Data gathered prove that circulating platelets are activated upon human allergic inflammation, partly as a result of direct IgE-mediated process. It has been indicated that platelets may contribute to pathogenesis of atopic eczema/dermatitis syndrome (AEDS). Authors of the recent study have investigated systemic platelet activation in patients with AEDS on the basis of blood level of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4), which are recognized markers of platelet activation, also belonging to C-X-C chemokine family. Plasma levels of beta-TG and PF4 were measured by enzyme-linked immunoassay (ELISA) in 18 AEDS patients with moderate disease activity and 23 healthy, nonatopic individuals. No differences in peripheral platelet count of the two groups were noted. Only four (33.3%) AEDS patients represented beta-TG and PF4 within the control range; plasma beta-TG and PF4 were significantly increased (p < 0.001) in the AEDS group compared as a whole with the control subjects. No association between circulating concentrations of beta-TG or PF4 and total IgE levels in AEDS patients was proved. The results suggest that some patients with AEDS may have enhanced blood platelet activity as expressed by beta-TG and PF4 level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Capron, A., J. C. Ameisen, M. Joseph, C. Auriault, A. B. Tonnel, and J. Caen. 1985. New functions for platelets and their pathological implications. Int. Arch. Allergy Appl. Immunol. 77:107–114.

    PubMed  Google Scholar 

  2. Cines, D. B., H. van der Keyl, and A. I. Levinson. 1986. In vitro binding of an IgE protein to human platelets. J. Immunol. 139:3433–3436.

    Google Scholar 

  3. Orchard, M. A., A. Kagey-Sobotka, D. Proud, and L. M. Lichtenstein. 1986. Basophil histamine release induced by a substance from stimulated human platelets. J. Immunol. 136:2240–2244.

    PubMed  Google Scholar 

  4. Hayashi, N., J. Chihara, Y. Kobayashi, T. Kakazu, D. Kurachi, T. Yamamoto, and S. Nakajima. 1994. Effect of platelet-activating factor and platelet factor 4 on eosinophil adhesion. Int. Arch. Allergy Immunol. 104(Suppl):57–59.

    Google Scholar 

  5. Burgers, J. A., R. C. Schweizer, L. Koenderman, P. L. Bruijnzeel, and J. W. Akkerman. 1993. Human platelets secrete chemotactic activity for eosinophils. Blood 81:49–55.

    PubMed  Google Scholar 

  6. Kaplan, K. L., and J. Owen. 1981. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57:199–202.

    PubMed  Google Scholar 

  7. Watanabe, O., K. Natori, M. Tamari, Y. Shiomoto, S. Kubo, and Y. Nakamura. 1999. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J. Hum. Genet. 44:173–176.

    Article  PubMed  Google Scholar 

  8. Kasperska-Zajac, A., B. Rogala, M. Nowakowski. 2003. Enhanced release of platelet factor 4 into the circulation in patients with the atopic eczema/dermatitis syndrome. Ann. Acad. Med. Bialostocensis. 48:128–130.

    Google Scholar 

  9. Hanifin, J., and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta. Derm. Venereol. (Stockh.). 92(Suppl):44–47.

    Google Scholar 

  10. Rajka, G., and T. Lageland. 1989. Grading of the severity of atopic dermatitis. Acta Derm. Venereol. (Stockh.). 144(Suppl):13–14.

    Google Scholar 

  11. Kurihara, Y., H. Nakayama, and S. Nakagawa. 1980. Plasma beta-thromboglobulin and platelet factor 4 in renal insufficiency. Thromb. Res. 18:557–560.

    PubMed  Google Scholar 

  12. Szczeklik, A., P. C. Milner, J. Birch, J. Watkins, and J. F. Martin. 1986. Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb. Haemost. 56:283–287.

    PubMed  Google Scholar 

  13. Gallagher, J. S., I. L. Bernstein, C. A. Maccia, G. L. Splansky, and H. I. Glueck. 1978. Cyclic platelet dysfunction in IgE-mediated allergy. J. Allergy Clin. Immunol. 62:229–235.

    Article  PubMed  Google Scholar 

  14. Rogala, B., J. Gumprecht, R. Gawlik, and K. Strojek. 1995. Platelet aggregation in IgE-mediated allergy with elevated soluble FcɛRII/CD23 level. J. Invest. Allergol. Clin. Immunol. 5:161–165.

    Google Scholar 

  15. Pitchford, S. C., H. Yano, R. Lever, Y. Riffo-Vasquez, S. Ciferri, M. J. Rose, S. Giannini, S. Momi, D. Spina, B. O’Connor, P. Gresele, and C. P. Page. 2003. Platelets are essential for leukocyte recruitment in allergic inflammation. J. Allergy Clin. Immunol. 112:109–118.

    Article  PubMed  Google Scholar 

  16. Rogala, B., J. Gumprecht, and J. Glück. 1999. Platelet aggregation in atopic dermatitis. Platelets. 10:341–344.

    Article  Google Scholar 

  17. Hilger, R. A., K. Neuber, and W. Konig. 1991. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 74:689–695.

    PubMed  Google Scholar 

  18. Neuber, K., R. A. Hilger, and W. König. 1992. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int. Arch. Allergy Immunol. 98:339–342.

    PubMed  Google Scholar 

  19. Elsner, J., and A. Kapp. 2000. Modulation of eosinophil effector function: The potential role for monoclonal antibodies and chemokine receptor antagonists. Allergy Asthma Proc. 21:345–349.

    PubMed  Google Scholar 

  20. Bruijnzeel, P. L. B., P. H. M. Kuijper, S. Rihs, S. Betz, R. A. J. Warringa, and L. Koenderman. 1993. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet activating factor, and platelet factor 4. J. Invest. Dermatol. 100:137–142.

    Article  PubMed  Google Scholar 

  21. Cahill, M. R., and A. C. Newland. 1993. Platelet activation in coronary artery disease. Br. J. Biomed Sci. 50:221–234.

    PubMed  Google Scholar 

  22. Sowers, J. R., and M. Epstein. 1995. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 26: 869–879.

    PubMed  Google Scholar 

  23. De Sousa, J. R., M. C. Santos, M. L. Carlos, and A. G. Carlos. 1992. Platelet reactivity to in vitro allergen challenge in asthmatic patients. Allergol. Immunopathol. 20:13–16.

    Google Scholar 

  24. Averill, F. J., W. C. Hubbard, D. Proud, G. J. Gleich, and M. C. Liu. 1992. Platelet activation in the lung after antigen challenge in a model of asthma. Am. Rev. Respir. Dis. 145:571–576.

    PubMed  Google Scholar 

  25. Yamamoto, H., M. Nagata, K. Tabe, I. Kimura, H. Kiuchi, Y. Sakamoto, K. Yamamoto, and Y. Dohi. 1993. The evidence of platelet activation in bronchial asthma. J. Allergy Clin. Immunol. 91:79–87.

    Article  PubMed  Google Scholar 

  26. Kasperska-Zajac, A., and B. Rogala. 2003. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflam. Res. 52:477–479.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alicja Kasperska-Zaj¸c.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kasperska-Zaj¸c, A., Nowakowski, M. & Rogala, B. Enhanced Platelet Activation in Patients with Atopic Eczema/Dermatitis Syndrome. Inflammation 28, 299–302 (2004). https://doi.org/10.1007/s10753-004-6054-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-004-6054-z

Key Words

Navigation